Basilea Pharmaceutica
BSLN.SW
#5986
Rank
HK$8.41 B
Marketcap
HK$679.27
Share price
0.14%
Change (1 day)
47.32%
Change (1 year)

EPS for Basilea Pharmaceutica (BSLN.SW)

EPS in 2025: HK$32.58

According to Basilea Pharmaceutica's latest financial reports the company's current EPS (TTM) is HK$32.58. In 2025 the company made an earnings per share (EPS) of HK$32.58 a decrease over its 2024 EPS that were of HK$55.72.

EPS history for Basilea Pharmaceutica from 2002 to 2025

Annual EPS

Year EPS Change
2025HK$32.58-41.53%
2024HK$55.72586.89%
2023HK$8.11-6.28%
2022HK$8.66-273.94%
2021-HK$4.98-60.87%
2020-HK$12.72-24.46%
2019-HK$16.83-26.92%
2018-HK$23.0359.83%
2017-HK$14.41-63.06%
2016-HK$39.01-19.26%
2015-HK$48.3246.12%
2014-HK$33.0710.07%
2013-HK$30.04-36.76%
2012-HK$47.50-5.42%
2011-HK$50.22-153.36%
2010HK$94.12-198.47%
2009-HK$95.58-15.34%
2008-HK$112.9016.7%
2007-HK$96.7436.07%
2006-HK$71.0979.07%
2005-HK$39.70-46.79%
2004-HK$74.619.83%
2003-HK$67.93-38.94%
2002-HK$111.25